Serina Therapeutics Stock Price Patterns
| SER Stock | 2.47 0.37 13.03% |
Momentum 55
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.43) | EPS Estimate Next Quarter (0.47) | EPS Estimate Current Year (2.13) | EPS Estimate Next Year (1.80) | Wall Street Target Price 13 |
Using Serina Therapeutics hype-based prediction, you can estimate the value of Serina Therapeutics from the perspective of Serina Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Serina Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Serina because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Serina Therapeutics after-hype prediction price | USD 2.84 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Serina Therapeutics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Serina Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Serina Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Serina Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Serina Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Serina Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Serina Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Serina Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Serina Therapeutics' historical news coverage. Serina Therapeutics' after-hype downside and upside margins for the prediction period are 0.14 and 10.20, respectively. We have considered Serina Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Serina Therapeutics is risky at this time. Analysis and calculation of next after-hype price of Serina Therapeutics is based on 3 months time horizon.
Serina Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Serina Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Serina Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Serina Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.28 | 7.36 | 0.00 | 0.03 | 12 Events / Month | 7 Events / Month | In about 12 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.47 | 2.84 | 0.00 |
|
Serina Therapeutics Hype Timeline
On the 5th of February Serina Therapeutics is traded for 2.47. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.03. Serina is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.28%. %. The volatility of related hype on Serina Therapeutics is about 7215.69%, with the expected price after the next announcement by competition of 2.50. About 47.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.92. Serina Therapeutics had not issued any dividends in recent years. The entity had 28:1000 split on the 15th of March 2024. Considering the 90-day investment horizon the next forecasted press release will be in about 12 days. Check out Serina Therapeutics Basic Forecasting Models to cross-verify your projections.Serina Therapeutics Related Hype Analysis
Having access to credible news sources related to Serina Therapeutics' direct competition is more important than ever and may enhance your ability to predict Serina Therapeutics' future price movements. Getting to know how Serina Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Serina Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GNTA | Genenta Science SpA | (0.17) | 6 per month | 0.00 | (0.30) | 6.47 | (12.34) | 33.85 | |
| SKYE | Skye Bioscience Common | (0.07) | 12 per month | 0.00 | (0.11) | 10.19 | (7.92) | 25.36 | |
| JUNS | Jupiter Neurosciences Common | 0.07 | 5 per month | 0.00 | (0.24) | 6.17 | (10.58) | 32.90 | |
| ALGS | Aligos Therapeutics | 0.36 | 10 per month | 0.00 | (0.02) | 10.16 | (8.73) | 28.43 | |
| BRNS | Barinthus Biotherapeutics plc | (0.08) | 7 per month | 0.00 | (0.20) | 5.71 | (9.09) | 24.01 | |
| INMB | INmune Bio | 0.15 | 10 per month | 0.00 | (0.03) | 6.82 | (7.91) | 22.66 | |
| XFOR | X4 Pharmaceuticals | (0.13) | 7 per month | 3.94 | 0.03 | 7.57 | (5.21) | 23.09 | |
| TELO | Telomir Pharmaceuticals Common | 0.04 | 5 per month | 0.00 | (0.11) | 4.58 | (6.00) | 17.75 | |
| GRCE | Grace Therapeutics | 0.03 | 7 per month | 1.80 | 0.08 | 3.80 | (2.51) | 12.43 | |
| CVM | CEL SCI Corp | 0.82 | 5 per month | 0.00 | (0.07) | 10.19 | (9.65) | 30.91 |
Serina Therapeutics Additional Predictive Modules
Most predictive techniques to examine Serina price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Serina using various technical indicators. When you analyze Serina charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Serina Therapeutics Predictive Indicators
The successful prediction of Serina Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Serina Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Serina Therapeutics based on analysis of Serina Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Serina Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Serina Therapeutics's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 0.48 | 0.11 | 0.0971 | 0.0923 | Revenue Per Share | 0.37 | 0.00761 | 0.008751 | 0.008314 |
Pair Trading with Serina Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Serina Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Serina Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Serina Stock
Moving against Serina Stock
| 0.86 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.71 | DSGN | Design Therapeutics | PairCorr |
| 0.68 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.6 | ENGN | enGene Holdings Common | PairCorr |
| 0.54 | 63E | ONWARD MEDICAL BV | PairCorr |
The ability to find closely correlated positions to Serina Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Serina Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Serina Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Serina Therapeutics to buy it.
The correlation of Serina Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Serina Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Serina Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Serina Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Serina Stock Analysis
When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.